Literature DB >> 17905828

Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low-density lipoproteins.

Catherine A Martin1, Emma Longman, Carol Wooding, Sarah J Hoosdally, Saira Ali, Timothy J Aitman, Daniel A P Gutmann, Paul S Freemont, Bernadette Byrne, Kenneth J Linton.   

Abstract

Cd36 is a small-molecular-weight integral membrane protein expressed in a diverse, but select, range of cell types. It has an equally diverse range of ligands and physiological functions, which has implicated Cd36 in a number of diseases including insulin resistance, diabetes, and, most notably, atherosclerosis. The protein is reported to reside in detergent-resistant microdomains within the plasma membrane and to form homo- and hetero-intermolecular interactions. These data suggest that this class B scavenger receptor may gain functionality for ligand binding, and/or ligand internalization, by formation of protein complexes at the cell surface. Here, we have overexpressed Cd36 in insect cells, purified the recombinant protein to homogeneity, and analyzed its stability and solubility in a variety of nonionic and zwitterionic detergents. Octylglucoside conferred the greatest degree of stability, and by analytical ultracentrifugation we show that the protein is monomeric. A solid-phase ligand-binding assay demonstrated that the purified monomeric protein retains high affinity for acetylated and oxidized low-density lipoproteins. Therefore, no accessory proteins are required for interaction with ligand, and binding is a property of the monomeric fold of the protein. Thus, the highly purified and functional Cd36 should be suitable for crystallization in octylglucoside, and the in vitro ligand-binding assay represents a promising screen for identification of bioactive molecules targeting atherogenesis at the level of ligand binding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905828      PMCID: PMC2211707          DOI: 10.1110/ps.073007207

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  31 in total

1.  CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction.

Authors:  L L Leung; W X Li; J L McGregor; G Albrecht; R J Howard
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

2.  Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis.

Authors:  J Savill; N Hogg; Y Ren; C Haslett
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

3.  Determination of molecular weight of the protein moiety in protein-detergent complexes without direct knowledge of detergent binding.

Authors:  J A Reynolds; C Tanford
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

4.  Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain. Evidence for a single calcium-dependent binding site on CD36.

Authors:  S Frieda; A Pearce; J Wu; R L Silverstein
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

5.  Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site.

Authors:  A C Nicholson; S Frieda; A Pearce; R L Silverstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-02       Impact factor: 8.311

6.  Expression cloning of SR-BI, a CD36-related class B scavenger receptor.

Authors:  S L Acton; P E Scherer; H F Lodish; M Krieger
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

7.  Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain.

Authors:  A S Asch; I Liu; F M Briccetti; J W Barnwell; F Kwakye-Berko; A Dokun; J Goldberger; M Pernambuco
Journal:  Science       Date:  1993-11-26       Impact factor: 47.728

8.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

9.  CD36 is a receptor for oxidized low density lipoprotein.

Authors:  G Endemann; L W Stanton; K S Madden; C M Bryant; R T White; A A Protter
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

10.  Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1991-12       Impact factor: 3.365

View more
  13 in total

1.  Identification and characterization of class B scavenger receptor CD36 from the hard tick, Haemaphysalis longicornis.

Authors:  Kyaw Min Aung; Damdinsuren Boldbaatar; Min Liao; Rika Umemiya-Shirafuji; Sumihiro Nakao; Terushige Matsuoka; Tetsuya Tanaka; Kozo Fujisaki
Journal:  Parasitol Res       Date:  2010-09-25       Impact factor: 2.289

2.  The multidrug resistance pump ABCB1 is a substrate for the ubiquitin ligase NEDD4-1.

Authors:  Begum G Akkaya; Joseph K Zolnerciks; Tasha K Ritchie; Bjoern Bauer; Anika M S Hartz; James A Sullivan; Kenneth J Linton
Journal:  Mol Membr Biol       Date:  2015-05-26       Impact factor: 2.857

3.  Optimization of Rutaecarpine as ABCA1 Up-Regulator for Treating Atherosclerosis.

Authors:  Yongzhen Li; Tingting Feng; Peng Liu; Chang Liu; Xiao Wang; Dongsheng Li; Ni Li; Minghua Chen; Yanni Xu; Shuyi Si
Journal:  ACS Med Chem Lett       Date:  2014-06-24       Impact factor: 4.345

4.  CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding.

Authors:  Anthony G Jay; Alexander N Chen; Miguel A Paz; Justin P Hung; James A Hamilton
Journal:  J Biol Chem       Date:  2015-01-01       Impact factor: 5.157

5.  Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2.

Authors:  Maximiliano J Jimenez-Dalmaroni; Nengming Xiao; Adam L Corper; Petra Verdino; Gary D Ainge; Dave S Larsen; Gavin F Painter; Pauline M Rudd; Raymond A Dwek; Kasper Hoebe; Bruce Beutler; Ian A Wilson
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

6.  The Human Scavenger Receptor CD36: glycosylation status and its role in trafficking and function.

Authors:  Sarah J Hoosdally; Edward J Andress; Carol Wooding; Catherine A Martin; Kenneth J Linton
Journal:  J Biol Chem       Date:  2009-04-15       Impact factor: 5.157

7.  Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL.

Authors:  Sangeeta R Kashyap; Adriana G Ioachimescu; Heather L Gornik; Thottathil Gopan; Michael B Davidson; Antonie Makdissi; Jennifer Major; Maria Febbraio; Roy L Silverstein
Journal:  Obesity (Silver Spring)       Date:  2009-06-11       Impact factor: 5.002

Review 8.  Thrombospondin-1: multiple paths to inflammation.

Authors:  Zenaida Lopez-Dee; Kenneth Pidcock; Linda S Gutierrez
Journal:  Mediators Inflamm       Date:  2011-07-03       Impact factor: 4.711

9.  Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver.

Authors:  Reto M Baertschiger; Véronique Serre-Beinier; Philippe Morel; Domenico Bosco; Marion Peyrou; Sophie Clément; Antonino Sgroi; André Kaelin; Leo H Buhler; Carmen Gonelle-Gispert
Journal:  PLoS One       Date:  2009-08-17       Impact factor: 3.240

10.  Insight into the mechanism of lipids binding and uptake by CD36 receptor.

Authors:  Zineb Tarhda; Azeddine Ibrahimi
Journal:  Bioinformation       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.